Recruitment - Articles

These days, we all have to be careful about discrimination in recruitment. It’s also worth remembering that you might be breaking the law if any discrimination happens during their recruitment process, even if you use a recruitment agency.
The key areas to avoid in your job adverts are: Age  discrimination Disability discrimination Gender discrimination Race or religion discrimination Firstly and most obviously, you must not include anything in your job advert that directly says you’ll discriminate against anyone. For example, you’re not allowed to state you can’t or won’t employ workers with a disability, of a certain age, gender etc. Be careful using phrases like ‘highly experienced’ or ‘recent graduate’ unless these are actual requirements of the job. Otherwise you may…

How to get the most out of your PharmiWeb.com banner
If you are using banners, these few tips can be used to help you get the most out of your Banner Advertising on PharmiWeb.com or anywhere else for that matter. Just increasing your Click Through Rate (CTR) by a few percent might make a huge difference to the success of your campaign. Pose Questions Try questions like “Did you know…” “Have you seen…” – the visitor who subconsciously reads the question will be enticed to take action. Some research shows that this can raise click through significantly. Bright Colours Bright colours can attract the eye, particularly where you’re competing with other banners and distractions. If you’re not constrained by branding, try Blue, Green or Yellow. White and Black are less effective. Make it Clea…

AI: The next frontier of innovation in life sciences
ProductLife Group’s Marco Anelli looks at the potential of artificial intelligence to change the way life sciences organisations operate. From discovery and development and throughout the entire product life cycle, artificial intelligence (AI) has already shaken up the life sciences industry by way of innovations such as AI-enabled drugs expected to be brought to market in the near future. But AI has the potential to go beyond that. Given the plethora of data all across the life sciences value chain, the ability to gather, manage, and effectively use intelligence from that data has posed a challenge. AI offers the chance to exploit the data in both structured and unstructured forms. Data that previously was hard to access or too difficu…

Master data management and addressing the forthcoming ISO IDMP standards
AMPLEXOR’s Sonia Monahan looks at what is involved in practice and how can life sciences firms ensure the investment pays off ISO IDMP compliance is more than just another regulatory hurdle for life sciences firms to straddle. It also promotes the kind of structure and discipline needed if organisations want to break new ground and take their businesses forward. It all begins with data though, and with assumptions about its quality, completeness, and reliability as an accurate record of operations.As EMA’s IDMP requirements near finalisation, the scale of the standards’ impact on managing regulatory data becomes more apparent. The transition from the current xEVMPD submission requirement to the more extensive and round…

This Salary Survey is jointly run by SciPro and PharmiWeb.
PharmiWeb have teamed up with SciPro to run the 2017 Salary & Trends Survey. By taking part in this survey. Take Part Today!

From slow start to rapid digitization: How IoT will transform the life sciences and healthcare supply chain
By Scott Allison, President, Life Sciences & Healthcare Sector, DHL Customer Solutions & Innovation The life sciences and healthcare industry as a whole has been slow to digitize. But things are starting to change now, fast-tracked by the growing phenomenon of the Internet of Things (IoT).  We are told that by 2020, more than 50 billion objects will be connected to the Internet (Cisco Consulting). So far, an absence of agreed industry standards and some genuine security concerns have restricted IoT innovation. But today there is clear evidence of an upswing in industry-specific applications, and it is only a matter of time before pharmaceutical and medical device compani…

Unless companies improve their use and manage data, they can’t hope to become more flexible, innovative or efficient, warns AMPLEXOR’S senior life sciences consultant, Siniša Belina.
Unless companies improve their use and manage data, they can’t hope to become more flexible, innovative or efficient, warns AMPLEXOR’S senior life sciences consultant, Siniša Belina. When markets as conservative and compliance oriented as banking and healthcare are being disrupted, it stands to reason that life sciences cannot afford to rest on its laurels. Whatever red tape it is shackled by, it too must heed the call to become more agile and innovative – able to respond to changing market demands. But there is a major sticking point: data. In the industries being disrupted, this has provided the key to new…

Stuart Britton provides an SEC Recruitment perspective on what the business has seen from pharmaceutical industry employers since the Brexit vote.
Stuart Britton, CEO of SEC Recruitment, provides a pharmaceutical recruiter's perspective on what SEC Recruitment has seen in the industry since the decision to leave the UK was made by the British public. When the announcement came through on 24th June 2016 that the UK public had voted to leave the European Union, my first reaction was to think of the people we have within SEC. We’re a multi-cultural business, speaking over 20 different languages and I knew that there would be some anxiety about what the future holds for individuals. So my immediate response was to communicate with the SEC team and tell them that whilst there would be a lot of n…

Life sciences cannot escape the call to transform itself as other industries have had to, warns Elvis Pacelat, Vice-President of Compliance Management at AMPLEXOR
Industries from retail to financial services have long accepted the need to digitally transform their operations. It paves the way for step changes in how brands operate, how they engage and get closer to customers, how they build market feedback into development cycles, how they drive new and repeat business, and how they identify and address new market opportunities.All of these challenges exist in the pharma industry too, so it seems surprising that companies here haven’t embraced the trend more enthusiastically.One of the biggest issues life sciences organisations grapple with is data, and visibility across processes. Commonly…

Even though regulatory requirements are already intensifying, data transformation plans in 2017 must extend beyond basic compliance if organisations want to be able to successfully navigate even bigger challenges in the life sciences market, warns Adam Sherlock, CEO of ProductLife Group.
Leaving aside intensified regulatory scrutiny, life sciences organisations still face a host of challenges as 2016 gives way to 2017. Globalisation, market consolidation, and calls for faster innovation and transformation are threatening existing business models and demanding that organisations begin to respond differently. Therefore, to survive and prosper, companies have to be breaking new ground by, for instance, exploring the impacts of looming trends towards preventive, collaborative health care, as we…

Visualising the Future
Modern manufacturing is an ecosystem of interconnected software and hardware that helps refineries, chemical and petrochemical companies optimise plants and achieve operational excellence. As businesses generate vast amounts of data, efficient decision support solutions are needed to make sense of vital information and ensure operations can adapt quickly to dynamic conditions.Today the terms, Industry 4.0 and the Internet of Things (IoT) are widely discussed across the engineering and manufacturing space, including ‘cloud’, ‘big data’. They all have a place to radically automate manufacturing, but they need to be clearly understood and positioned in context with the manufacturer’s operational and commercial objectives.This article aims to de-mystify buzz-terms that c…

This November 9th 2016, the entire world awoke to the “Supremacy of Presidential Entrepreneurialism.” After a couple of hundred years and the first time in US history, the White House now will be occupied by a non-politician and a world-class entrepreneur, President Elect Donald Trump.
This earth shattering event is a powerful wake up call to all the political leaders of the world; many of whom are already afraid of losing their own next election.  There is a fear of draining of swamps; structured bureaucracies and layered incompetencies are now desperately trying to come up with brand new prosperity plans. Trumpization of America, the strategic blue print of Trump’s election victory game plan is now available as a working guide and a mandatory curriculum for the decimated senior poli…

Are you wondering why your recruitment job adverts don’t seem to work anymore and do you want to start doing something about it? Your candidates have changed.
The prevalence of the internet and modern marketing methods means that your candidates have changed. They are more marketing savvy and are bored by seeing the same old type of demanding recruitment ads they’ve seen for years. Ads that aren’t targeted well and don’t talk to them in the right tone. Ads that don’t grab their attention and look tediously similar with a traditional type of layout – Job Description, Requirements, bullets, more bullets …(that’s if it isn’t all in one hard to digest paragraph!) Candidates are consumers now and are used to being marketed to, preferably in a sophisticated and intelligent way.Highly…

Why a meaningful brand is a pharma’s greatest asset
Pharmaceutical companies are under increasing pressure to deliver safe, efficacious and cost-effective drugs, while continuing to be innovative, compliant and profitable.Sustaining competitive advantage has never been more difficult, and businesses are struggling to deliver revenue and growth: Pfizer’s revenues have decreased 28% since 2012, and AstraZeneca’s by 26%. One powerful way companies can safeguard against diminishing shareholder value and returns is to invest in building strong brand equity.With physicians no longer the sole influencers in prescribing and drug purchase decisions; and patients having more access to information about conditions and treatment options than ever before, there is an expanding variety of forces shaping…

How innovating for emerging markets is set to disrupt the global surgical care industry
The growth of emerging markets is poised to transform the delivery of surgical care around the world by 2030, according to a new report. The emphasis will be on affordable technology for early diagnosis; portable modular equipment for minimally invasive and robotic surgery; and smart systems incorporating low-cost sensors and mobile technology to track clinical outcomes and improve team-based surgery.The report summarises the findings of a workshop held in Boston earlier this year by product design and development firm Cambridge Consultants. It offers unique insight into the future of emerging markets surgical care – as seen through the eyes of industry leaders. And it looks at how these new approaches t…

The drive towards preventative healthcare is placing new focus on food – from the dietary qualities of packaged produce, to the health claims of so-called ‘nutraceuticals’. It has captured the imagination of governments, healthcare providers, the general public, and the life sciences industry. But it has also woken the regulatory giants, who are now drawing up new standards for information and labelling, says Peter Muller of Schlafender Hase
Regulators’ growing interest in food and nutraceuticals (foods with added health benefits) reflects growing government interest in helping consumers to make better dietary choices. This will affect the pharma industry, which wants its share of these adjacent market opportunities. Nutraceuticals in particular offers a new take on preventative healthcare…

Empowering experts, retaining talent
It’s hard enough for pharma organisations to find and keep top regulatory talent in the current climate, so the last thing they can afford is to lose valued skills to a competitor. To reduce their exposure, firms need to automate more of their routine processes, relieving pressure on overstretched employees while giving them a better quality of working life, says Dr. Jutta Hohenhörst of Schlafender HaseEven without the implications of Brexit, these are turbulent times for regulatory teams. Compliance has become a full-time job, and administrative demands are on a permanently upward trajectory.The more rules there are, and the more frequently these change, the greater the risk of something going wrong (with product labelling, for example). Often it is hig…

Compliance - more than just red tape Using regulatory criteria to improve product quality
A growing customer demand for regulatory compliance combined with increased competition amongst manufacturers has made SCADA software a minimum requirement for the pharmaceutical industry. Here, Lee Sullivan, Regional Manager at COPA-DATA UK discusses why today, more than ever before, regulatory compliance is crucial for the pharmaceutical industry.FDA statistics are forcing the industry to identify and implement improvements to its manufacturing processes. In its latest reports, the FDA identified a significant increase in the number of drug shortages reported globally. With 65% of these drug shortage instances directly caused by issues in product quality, it’s clear that if more pharma manufa…

Alexander Mann Solutions
The culture of the pharmaceutical sector reveres talent and experience above all else – and with good reason. However, at a time when cuts in government spending, patent cliffs, significant talent shortages, and shifts in business focus between therapeutic areas are all threatening the stability of the sector, how can organisations best manage their workforces to ensure future success and profitability?As a historically cash-rich industry, pharma has long had the freedom to hire at will, often from within, but bold new business models coupled with drives towards efficiency are rapidly changing talent needs. The traditional approach to managing skill shortages has been to draft in expertise with little consideration to cost. While this strategy has worked well in t…

On-tap analytics: the key to getting ahead in 2016
Whether it’s meeting new regulatory imperatives or the need to position products differently, there are a wealth of challenges facing life sciences companies - and the key to overcoming most of them is the intelligence locked inside everyday data, says Elvis Paćelat, VP Compliance Solutions at AMPLEXOR Life SciencesThe root of the problem seems to be that information capture, management and discovery projects in the industry have evolved according to specific individual requirements; they have not be aligned with a broader vision for business transformation. But the hope is that this will change in 2016, because of intensifying competitive pressures, the need for new business models, and the requirement to be much more transparent with cust…